Effect of Different Dialyzer Membranes on Serum Angiotensin-Converting Enzyme during Hemodialysis

The effects of different dialyzer membranes on serum concentration of angiotensin-converting enzyme (ACE) and white blood cells during hemodialysis were examined on a cross-over basis in 20 chronically uremic patients. Hemodialysis with cuprophane membranes was associated with a significant (p < 0.001) fall in the mean leukocyte count during the 1st hour of treatment. The use of polymethylmetacrylate membranes resulted in a more attenuated form of leukopenia and with polyacrylonitrile membranes no change was observed during hemodialysis. Hemodialysis with each membrane caused a comparable, significant (p < 0.005) increase in serum ACE, independent of the degree of leukopenia but significantly (p < 0.001) correlated with the increases in serum proteins. We conclude that this increase in serum ACE concentration after hemodialysis does not reflect acute damage of the pulmonary vascular endothelium during treatment and most probably is a result of hemoconcentration. Therefore, serum ACE analysis is not an indicator of dialyzer membrane biocompatibility.